$HBIO 4 SEC Filings

Filed On	Filing
12 Jun 2026	Form 4: Eade Katherine A., Director Received 16,556 shares as a grant or award
11 Jun 2026	Form 4: Snider William, Director Received 16,556 shares as a grant or award
11 Jun 2026	Form 4: Denelsky Stephen J, Director Received 16,556 shares as a grant or award
11 Jun 2026	Form 4: Gagnon Robert E., Director Received 16,556 shares as a grant or award
11 Jun 2026	Form 4: Benson Seth Benjamin, Director Received 16,556 shares as a grant or award
01 Apr 2026	Form 4: Frost Mark T, Chief Financial Officer Received 30,000 shares as a grant or award
01 Apr 2026	Form 4: Frost Mark T, Chief Financial Officer Bought 5,000 shares ($25K)
23 Mar 2026	Form 4: Duke John D, Director Received 75,000 shares as a grant or award
18 Mar 2026	Form 4: Denelsky Stephen J, Director Bought 10,000 shares ($48.7K)
18 Mar 2026	Form 4: Snider William, Director Bought 12,525 shares ($62.5K) · Bought 8,475 shares ($41.1K)
17 Mar 2026	Form 4: Duke John D, Director Bought 5,000 shares ($25.1K)
30 Dec 2025	Form 4: Snider William, Director Received 110,000 shares as a grant or award
07 Oct 2025	Form 4: Denelsky Stephen J, Director Received 110,000 shares as a grant or award
19 Aug 2025	Form 4: Green James W, Director Returned 347,782 shares to the issuer · Gave up 44,740 shares to cover exercise price or tax ($23.7K)
11 Aug 2025	Form 4: Duke John D, Director Received 1,000,000 shares as a grant or award
25 Jul 2025	Form 4: Benson Seth Benjamin, Director Received 110,000 shares as a grant or award
18 Jul 2025	Form 4: Eade Katherine A., Director Received 110,000 shares as a grant or award
18 Jul 2025	Form 4: Gagnon Robert E., Director Received 110,000 shares as a grant or award
14 May 2025	Form 4: Frost Mark T, Interim CFO Received 100,000 shares as a grant or award
21 Mar 2025	Form 4: Cote Jennifer, Chief Financial Officer Gave up 5,687 shares to cover exercise price or tax ($3.92K)

Comments